-transparent.png){kind=logo}
Mitomycin C (MMC), a bifunctional alkylating agent, requires metabolic reduction to become biologically active. We have identified a series of genetically related Chinese hamster ovary cell lines which span approximately three orders of magnitude in the concentration of MMC required for cell killing. Many mechanisms, including drug transport, drug activation, drug detoxification, and the elimination, or repair, of drug-induced lesions, may contribute to the level of drug resistance in cells. By exploring each of the above mechanisms in the various Chinese hamster ovary cell lines, we have been able to classify these cell lines into four categories. Proceeding from least resistant to most resistant to MMC, the cell lines are: (a) proficient in the bioreduction of MMC and deficient in DNA excision repair; (b) deficient in some aspects of MMC bioreduction and deficient in repair; (c) bioreduction and repair proficient; and (d) bioreduction deficient and repair proficient.
A M Dulhanty, and
M Li, and
G F Whitmore
June 2001,
Journal of biochemistry,
A M Dulhanty, and
M Li, and
G F Whitmore
November 1986,
Mutation research,
A M Dulhanty, and
M Li, and
G F Whitmore
November 1985,
Cancer research,
A M Dulhanty, and
M Li, and
G F Whitmore
January 1988,
The Journal of biological chemistry,
A M Dulhanty, and
M Li, and
G F Whitmore
September 1994,
Mutagenesis,
A M Dulhanty, and
M Li, and
G F Whitmore
December 2006,
Biochimica et biophysica acta,
A M Dulhanty, and
M Li, and
G F Whitmore
April 2002,
Biochemical and biophysical research communications,
A M Dulhanty, and
M Li, and
G F Whitmore
May 1997,
Experimental cell research,
A M Dulhanty, and
M Li, and
G F Whitmore
July 1980,
Proceedings of the National Academy of Sciences of the United States of America,
A M Dulhanty, and
M Li, and
G F Whitmore
March 1987,
Cancer research,
